Literature DB >> 23078924

Pathological reassessment of hyperplastic colon polyps in a city-wide pathology practice: implications for polyp surveillance recommendations.

Harminder Singh1, Diane Bay, Stephen Ip, Charles N Bernstein, Zoann Nugent, Rodica Gheorghe, Robert Wightman.   

Abstract

BACKGROUND: Sessile serrated adenomas (SSAs) and hyperplastic polyps (HP) are the two most common types of serrated colon polyps (SCPs). SSAs are suspected to be the precursor lesions for many colorectal cancers, and hence there is an emphasis on their detection and removal. On the other hand, recent guidelines such as those from the European Union consider HPs of limited clinical significance.
OBJECTIVE: Evaluate the reclassification rate of recently diagnosed HPs to SSAs and the predictors of such reclassification. DESIGN, SETTING, INTERVENTION, MAIN OUTCOME MEASUREMENTS: The provincial pathology database was searched for all colon polyps reported in the 6 pathology laboratories in the city of Winnipeg in 2009. All retrieved pathology slides for previously reported right-sided HPs and a 20% random sample of left-sided HPs were reassessed by two pathologists with a special interest in GI pathology. Polyp size, colon location, and age and sex of the study participants were evaluated as potential predictors of reclassification.
RESULTS: A total of 4096 pathology reports by 25 different pathologists were reviewed. Twenty percent of the polyps were reported as SCPs. Seventeen percent of right-sided previously reported HPs and 20% of those >5 mm were reclassified as SSAs. Size >5 mm (odds ratio [OR] 4.2; 95% confidence interval [CI], 1.5-11.4) and location in the right side of the colon (OR 4.7; 95% CI, 1.4-15.4) were independent predictors of reclassification. LIMITATIONS: Retrospective review.
CONCLUSION: A significant proportion of recently reported right-sided HPs may be SSAs. Surveillance recommendations for SCPs should consider the size and location of SCPs and not just the reported type.
Copyright © 2012 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23078924     DOI: 10.1016/j.gie.2012.07.026

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  23 in total

Review 1.  Endoscopic and histologic characteristics of serrated lesions.

Authors:  Driffa Moussata; Gilles Boschetti; Marion Chauvenet; Karine Stroeymeyt; Stéphane Nancey; Françoise Berger; Thierry Lecomte; Bernard Flourié
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

2.  Sessile serrated polyps: detection, eradication, and prevention of the evil twin.

Authors:  Joshua C Obuch; Courtney M Pigott; Dennis J Ahnen
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

3.  Increased risk of metachronous large serrated polyps in individuals with 5- to 9-mm proximal hyperplastic polyps: data from the New Hampshire Colonoscopy Registry.

Authors:  Joseph C Anderson; Christina M Robinson; Lynn F Butterly
Journal:  Gastrointest Endosc       Date:  2020-04-26       Impact factor: 9.427

4.  Risk of Metachronous High-Risk Adenomas and Large Serrated Polyps in Individuals With Serrated Polyps on Index Colonoscopy: Data From the New Hampshire Colonoscopy Registry.

Authors:  Joseph C Anderson; Lynn F Butterly; Christina M Robinson; Julia E Weiss; Christopher Amos; Amitabh Srivastava
Journal:  Gastroenterology       Date:  2017-09-18       Impact factor: 22.682

5.  Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis.

Authors:  D H Johnson; S Khanna; T C Smyrk; E V Loftus; K S Anderson; D W Mahoney; D A Ahlquist; J B Kisiel
Journal:  Aliment Pharmacol Ther       Date:  2014-04-30       Impact factor: 8.171

6.  Impact of fair bowel preparation quality on adenoma and serrated polyp detection: data from the New Hampshire colonoscopy registry by using a standardized preparation-quality rating.

Authors:  Joseph C Anderson; Lynn F Butterly; Christina M Robinson; Martha Goodrich; Julia E Weiss
Journal:  Gastrointest Endosc       Date:  2014-05-10       Impact factor: 9.427

7.  Colorectal cancer surveillance after index colonoscopy: guidance from the Canadian Association of Gastroenterology.

Authors:  Desmond Leddin; Robert Enns; Robert Hilsden; Carlo A Fallone; Linda Rabeneck; Daniel C Sadowski; Harminder Singh
Journal:  Can J Gastroenterol       Date:  2013-04       Impact factor: 3.522

8.  Factors associated with reclassification of hyperplastic polyps after pathological reassessment from screening and surveillance colonoscopies.

Authors:  Christoph Schramm; Moritz Kaiser; Uta Drebber; Inga Gruenewald; Jeremy Franklin; Fabian Kuetting; Andrea Bowe; Vera Hoffmann; Sebastian Gatzke; Ulrich Toex; Hans-Michael Steffen
Journal:  Int J Colorectal Dis       Date:  2015-09-29       Impact factor: 2.571

Review 9.  Update on colon cancer screening: recent advances and observations in colorectal cancer screening.

Authors:  Joseph C Anderson; Robert D Shaw
Journal:  Curr Gastroenterol Rep       Date:  2014-09

Review 10.  Serrated neoplasia of the colon: what do we really know?

Authors:  Tanvir Haque; Kevin G Greene; Seth D Crockett
Journal:  Curr Gastroenterol Rep       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.